Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | BBOX1 | O75936 | 6/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.39 |
| ▸ | FABP3 | P05413 | 5/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL673674 | 0.88 | CA1 (0.39) | CA1BBOX1FFAR3HDAC3HDAC1 | |
| SCHEMBL3680942 | 0.85 | BBOX1 (0.38) | CA1BBOX1FFAR3HDAC3HDAC1 | |
| SCHEMBL1082921 | 0.83 | ACLY (0.38) | CA1BBOX1 | |
| SCHEMBL4605976 | 0.83 | CA1 (0.41) | CA1BBOX1FFAR3HDAC3HDAC1 | |
| SCHEMBL673918 | 0.82 | CA1 (0.47) | CA1BBOX1FFAR3HDAC3HDAC1 | |
| SCHEMBL674546 | 0.82 | CA1 (0.38) | CA1BBOX1 | |
| SCHEMBL6740718 | 0.81 | FFAR3 (0.42) | CA1BBOX1FFAR3HDAC3HDAC1 | |
| Potassium Ion SCHEMBL8582760 | 0.81 | FFAR3 (0.42) | CA1BBOX1FFAR3HDAC3HDAC1 | |
| SCHEMBL6931562 | 0.81 | FFAR3 (0.46) | CA1BBOX1FFAR3HDAC3HDAC1 | |
| SCHEMBL30590536 | 0.81 | CA1 (0.48) | CA1BBOX1FFAR3HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | CA1 2042/4885BBOX1 3086/4885FFAR3 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.